The global vaccine alliance Gavi has successfully secured $9 billion in new funding during its 2025 Vaccine Investment Summit, a critical step toward maintaining immunization programs in lower-income countries. Though the amount falls short of its $11.9 billion target, it ensures the continuity of life-saving vaccination campaigns for over 1 billion children by 2030.
A Lifeline for Global Health Equity
Since its founding in 2000, Gavi has helped immunize more than 1 billion children, preventing over 17 million deaths. The 2025 funding round reaffirms the alliance’s mission to:
- Protect the most vulnerable children from vaccine-preventable diseases
- Support COVID-19 vaccine equity
- Expand access to new vaccines like HPV, malaria, and RSV
“Vaccines are the best investment in global health,” said José Manuel Barroso, Chair of the Gavi Board.
Who Pledged What?
Key contributors at the summit include:
- United Kingdom: £1 billion (≈$1.27 billion)
- Bill & Melinda Gates Foundation: $1.58 billion
- European Commission: €1 billion
- United States: $500 million (a decrease from previous rounds)
- Norway, Germany, and Canada also pledged strong multi-year support
Despite these efforts, experts have raised concerns over the shortfall of nearly $3 billion, especially given increasing disease threats and climate-linked outbreaks.
Challenges Ahead
- Vaccine hesitancy and misinformation remain widespread
- Fragile healthcare infrastructure in war-torn or disaster-hit areas
- Need for cold-chain logistics and digital vaccine tracking tools
- Gavi must now adapt and prioritize high-impact, low-resource strategies
Still, leaders emphasized that even partial funding secures Gavi’s core mission of global vaccine access through 2030.
Key Takeaways:
- Gavi raised $9 billion to support childhood immunization in 2025–2030.
- Falls short of the $11.9B goal, risking program scale-backs in underserved regions.
- Funding supports vaccines for measles, polio, HPV, and more.
- Major contributors include the UK, Gates Foundation, and EU.
Source: Reuters – Gavi Secures $9 Billion After 2025 Vaccine Funding Summit
